PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.\', \'Department of Immunology, School of Medicine, UConn Health, Farmington, CT 06032, USA.\', \'Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.\', \'Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.\', \'Department of Dermatology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430014, China tjhappy@126.com goldcoindaniel@163.com.\', \'Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China tjhappy@126.com goldcoindaniel@163.com.\', \'Hubei Engineering Research Center for Skin Repair and Theranostics, Wuhan 430022, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00159310.1136/jitc-2020-001593
?:doi
?:hasPublicationType
?:journal
  • Journal for immunotherapy of cancer
is ?:pmid of
?:pmid
?:pmid
  • 33303577
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.798
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • Management of immune checkpoint therapy for patients with cancer in the face of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33303577>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33303577>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all